During the period February–July all Nordic markets continued to rise even more than expected. On average the markets grew by 6.6 percent compared to 3.8 % for the same period last year. However, intense competition kept the margins low. The wholesale margins are modest compared to the margins of the other parties in the pharmaceutical industry.

The Baltic markets continued to post good growth as well. The average market growth was 17%. These markets are characterized by high inflation and unstable economic growth. In spite of the good growth, pharmaceutical consumption is far below the EU average.